Avecho Biotechnology Ltd has released a press release.
Phosphagenics Licensing Agreement Update
Filed with ASX ·
6ix hasn’t read this filing yet.
Avecho Biotechnology Limited on 6ix
Earlier from Avecho Biotechnology
- Half Year Accounts
- AGM Chairmans Address and CEO Presentation
- Terumo Shifts Focus From Oxymorphone Patch to Injectables
- Preliminary Final Report
- Phosphagenics Placement Secures A$1.37 million
Later from Avecho Biotechnology
- Phosphagenics Receives Further Arbitration Process Update
- Phosphagenics Arbitration Award Issued
- Suspension from Official Quotation
- Phosphagenics and Mylan Agree Settlement
- Reinstatement to Offical Quotation
Follow Avecho Biotechnology into a list and get an email when it puts out news.
Follow Avecho Biotechnology